Quantum BioPharma (NASDAQ: QNTM) , a biopharmaceutical company focused on innovative biotech solutions, has filed an amended complaint in the U.S. Di ...

The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices ...

The global Digital Twins in Healthcare Market, valued at US$2.69 billion in 2024, is forecasted to grow at a robust CAGR of ...

Jacobs Solutions, Inc. is a holding company, which engages in the designing and deployment of technology-centric solutions. It operates through the following business segments: Critical Mission ...

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating ...

Cardinal Health, Inc. CAH reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.35, which beat the Zacks ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

Baxter International Inc. BAX is scheduled to release first-quarter 2025 results on May 1, before the opening bell. In the ...

Quantum BioPharma (NASDAQ: QNTM) has appointed Kevin Malone as an advisor to its Board of Directors. A seasoned financial advisor with over 40 years ...

UPS is expanding its precision logistics capabilities in the pharmaceutical and life sciences sectors with an agreement to ...

Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.